These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21887328)

  • 1. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
    Ghose J; Sinha M; Das E; Jana NR; Bhattacharyya NP
    PLoS One; 2011; 6(8):e23837. PubMed ID: 21887328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
    Choudhury KR; Das S; Bhattacharyya NP
    J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.
    Sinha M; Ghose J; Das E; Bhattarcharyya NP
    Biochem Biophys Res Commun; 2010 Jun; 396(3):742-7. PubMed ID: 20451497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Cell Cycle Progression in STHdh(Q111)/Hdh(Q111) Cells, a Cell Model for Huntington's Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432.
    Das E; Jana NR; Bhattacharyya NP
    Microrna; 2015; 4(2):86-100. PubMed ID: 26165466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells.
    Das E; Jana NR; Bhattacharyya NP
    Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.
    Ghose J; Bhattacharyya NP
    RNA Biol; 2015; 12(4):457-77. PubMed ID: 25757558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients.
    Laprairie RB; Warford JR; Hutchings S; Robertson GS; Kelly ME; Denovan-Wright EM
    J Neuroimmunol; 2014 Feb; 267(1-2):61-72. PubMed ID: 24360910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro RNA -214,-150,-146a and-125b target Huntingtin gene.
    Sinha M; Ghose J; Bhattarcharyya NP
    RNA Biol; 2011; 8(6):1005-21. PubMed ID: 22048026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
    Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
    Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
    Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
    Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
    Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
    Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
    Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
    Trettel F; Rigamonti D; Hilditch-Maguire P; Wheeler VC; Sharp AH; Persichetti F; Cattaneo E; MacDonald ME
    Hum Mol Genet; 2000 Nov; 9(19):2799-809. PubMed ID: 11092756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.
    Anglada-Huguet M; Giralt A; Perez-Navarro E; Alberch J; Xifró X
    J Neurochem; 2012 May; 121(4):639-48. PubMed ID: 22372926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro RNA-214 contributes to proteasome independent downregulation of beta catenin in Huntington's disease knock-in striatal cell model STHdhQ111/Q111.
    Ghatak S; Raha S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):509-14. PubMed ID: 25747711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.